Searched for
MARCK BIOSCIENCES MARCK BIOSCIENCES
Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 crGlobal investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a ...- Quant Mid Cap Fund adds Adani Energy and 4 others, exits Paytm and 3 more stocks in MayQuant Mid Cap Fund, managed by Sandeep Tandon, has strategically adjusted its portfolio in May. The fund added Adani Energy and four other ...
- Forget CS or AI? This once-overlooked engineering stream quietly becomes the surprise choice among IIT aspirantsCivil engineering has surprisingly surged in popularity among top-ranked students for IIT admissions in 2026, with significant rank improve...
- Ashoka University appoints Professor Rishikesha T. Krishnan as its next vice-chancellorAshoka University has appointed Professor Rishikesha T. Krishnan as its next Vice-Chancellor, effective August 1, 2026. A distinguished sch...
- Several red flags emerge as SpaceX IPO hawks Elon Musk's Mars dreamSpaceX's bold Mars vision faces scientific doubts. Experts highlight engineering challenges and human biology unknowns. Colonizing Mars pre...
- As AI shifts from training to inference, Intel moves up the stackIntel is changing its AI strategy. The company is now focusing on building complete AI systems and infrastructure, not just chips. This mov...
- Intel CEO unveils AI innovations and partnerships at mega tech event in TaiwanIntel unveiled new AI-focused technologies, strategic collaborations, and next-generation processors at Computex 2026. The company announce...
- FIIs pull out massive Rs 20,637 crore in single day on Friday. What led to this sharp exit?Foreign portfolio investors offloaded Indian equities worth a net Rs 20,637 crore on Friday, marking one of the sharpest single-day selloff...
- Ahead of Market: 10 things that will decide stock market action on FridayDomestic equity benchmarks ended marginally lower for a second consecutive session as weakness in financial, IT and energy shares offset ga...
- What AI’s entry into de-extinction research says about modern biologyArtificial intelligence is increasingly being used to process complex genetic data, enabling new approaches in biological research. This sh...
- Hantavirus scare a wake-up call: Why India must build its disease X defencesA recent hantavirus outbreak on a cruise ship echoes past pandemic scares. Experts warn Disease X, a future unknown pathogen, is a near cer...
- Shastra VC launches $100 million fund to back deeptech, AI startupsThe Bengaluru-based firm said the new vehicle will invest between $500,000 and $3 million in IP-led firms across these sectors. The launch ...
- Piper Serica launches Rs 800 crore Bharat Tech Fund for investment in Indian tech startupsPiper Serica has launched the Bharat Tech Fund. This new fund aims to raise Rs 800 crore. It will invest in Indian technology startups. The...
- Global Market: Hong Kong IPO boom draws rising interest from overseas companiesHong Kong's stock market is seeing more foreign companies file for listings. Firms from countries like Indonesia and South Korea are explor...
- Federal Bank, Indian Bank, MCX & Nalco in MSCI GlobalGlobal index provider MSCI has announced significant changes to its indices. Federal Bank, Indian Bank, Multi Commodity Exchange of India, ...
- Tata Capital buys 19% stake in Marck BiosciencesThe Fund Infusion from Tata Capital will be invested for further expansion of capacities of the new project which will have state of the ar...
- South Africa approves six Marck Biosciences pharma productsThe South African market worth around $ 3.8 billion (2011), is growing at the rate of six per cent and is expected to reach $ 7 billion by ...
- South Africa drug authority approves Marck's 6 productsSix products have obtained approvals from MCC-South Africa, including Sterile Water for injections and Ciprofloxacin Eye Drops among others.
- Intas gets SEBI nod for IPO for raising Rs 800 croreIntas Pharmaceuticals has received SEBI clearance for its IPO. The issue was expected to hit the market in May, but Intas is still undecide...
- Marck Biosciences plans to enter Latin American marketDrug manufacturer Marck Biosciences is planning to enter the Latin American market and has got the nod from the Brazilian healthcare watchd...
Load More
